Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Passiflora extract for benzodiazepine withdrawal in institutionalized older adults
2017-004514-25Phase 3Terminated
- Sponsor
- Nutrición Médica
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Sedistress in benzodiazepine dependence and benzodiazepine withdrawal syndrome (BWS) (2 arms), sponsored by Nutrición Médica. Primary endpoint: Primary: benzodiazepine dose reduction. Started Jun 2018; status: terminated.
02
Drugs
Sedistress
03
Conditions
benzodiazepine dependencebenzodiazepine withdrawal syndrome (BWS)
Beyond the preview
Go deeper on 2017-004514-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004514-25.